These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 20921230

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB, Tewson P, Bruederle CE, Skach WR, Shyng SL.
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phosphatidylinositol-4,5-bisphosphate, PIP2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels.
    Loussouarn G, Park KH, Bellocq C, Baró I, Charpentier F, Escande D.
    EMBO J; 2003 Oct 15; 22(20):5412-21. PubMed ID: 14532114
    [Abstract] [Full Text] [Related]

  • 29. Long polyamines act as cofactors in PIP2 activation of inward rectifier potassium (Kir2.1) channels.
    Xie LH, John SA, Ribalet B, Weiss JN.
    J Gen Physiol; 2005 Dec 15; 126(6):541-9. PubMed ID: 16316973
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Activation of inwardly rectifying potassium (Kir) channels by phosphatidylinosital-4,5-bisphosphate (PIP2): interaction with other regulatory ligands.
    Xie LH, John SA, Ribalet B, Weiss JN.
    Prog Biophys Mol Biol; 2007 Jul 15; 94(3):320-35. PubMed ID: 16837026
    [Abstract] [Full Text] [Related]

  • 32. Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies.
    Lopes CM, Zhang H, Rohacs T, Jin T, Yang J, Logothetis DE.
    Neuron; 2002 Jun 13; 34(6):933-44. PubMed ID: 12086641
    [Abstract] [Full Text] [Related]

  • 33. Identification of the PIP2-binding site on Kir6.2 by molecular modelling and functional analysis.
    Haider S, Tarasov AI, Craig TJ, Sansom MS, Ashcroft FM.
    EMBO J; 2007 Aug 22; 26(16):3749-59. PubMed ID: 17673911
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Carvedilol inhibits Kir2.3 channels by interference with PIP₂-channel interaction.
    Ferrer T, Ponce-Balbuena D, López-Izquierdo A, Aréchiga-Figueroa IA, de Boer TP, van der Heyden MA, Sánchez-Chapula JA.
    Eur J Pharmacol; 2011 Oct 01; 668(1-2):72-7. PubMed ID: 21663737
    [Abstract] [Full Text] [Related]

  • 37. Long chain CoA esters as competitive antagonists of phosphatidylinositol 4,5-bisphosphate activation in Kir channels.
    Rapedius M, Soom M, Shumilina E, Schulze D, Schönherr R, Kirsch C, Lang F, Tucker SJ, Baukrowitz T.
    J Biol Chem; 2005 Sep 02; 280(35):30760-7. PubMed ID: 15980413
    [Abstract] [Full Text] [Related]

  • 38. Phosphatidylinositol 4,5-bisphosphate and intracellular pH regulate the ROMK1 potassium channel via separate but interrelated mechanisms.
    Leung YM, Zeng WZ, Liou HH, Solaro CR, Huang CL.
    J Biol Chem; 2000 Apr 07; 275(14):10182-9. PubMed ID: 10744702
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.